JSKN016HC

· Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JSKN016HC, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors [Phase 1]